Search criteria | ||||
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | ||||
Avraham Karasik (1), Stefanie Lanzinger (2,3), Elise Chia-Hui Tan (4), Daisuke Yabe (5,6,7 8), Dae Jung Kim (9), Wayne H-H Sheu (10), Cheli Melzer-Cohen (1), Reinhard W. Holl (2), Kyoung-Hwa Ha (9), Kamlesh Khunti (11), Francesco Zaccardi (11), Anuradhaa Subramanian (12), Krishnarajah Nirantharakumar (12,13,14), Thomas Nyström (15), Leo Niskanen (16), Majken Linnemann Jensen (17), Fabian Hoti (18), Riho Klement (19), Anouk Déruaz-Luyet (20), Moe H.Kyaw (21), Lisette Koeneman (22), Dorte Vistisen (23, 24) Bendix Carstensen (23), Sigrun Halvorsen (25), Gisle Langslet (26), Soulmaz Fazeli Farsani (20), Elisabetta Patorno (27), Júlio Núñez (28), EMPRISE Europe and Asia Study Group | ||||
"1 Maccabi Institute for Research and Innovation Center, Tel Aviv University, Tel Aviv, Israel 2 Institute for Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany 3 German Centre for Diabetes Research (DZD), München-Neuherberg, Germany 4 Department of Health Service Administration, China Medical University, Taichung, Taiwan 5 Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kyoto, Japan 6 Department of Diabetes, Metabolism and Endocrinology/Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan 7 Center for Healthcare Information Technology, Tokai National Higher Education and Research System, Nagoya, Japan 8 Preemptive Food Research Center, Gifu University Institute for Advanced Study, Gifu, Japan 9 Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea 10 Division of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan 11 Leicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK 12 Institute of Applied Health Research, University of Birmingham, Birmingham, UK 13 Midlands Health Data Research UK, Birmingham, UK 14 DEMAND Hub, University of Birmingham, Birmingham, UK 15 Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Sweden 16 Päijät-Häme Joint Authority for Health and Wellbeing, Päijät-Häme Central Hospital, Lahti Finland and University of Eastern Finland, Kuopio, Finland 17 IQVIA Solutions Denmark A/S, Copenhagen, Denmark 18 IQVIA, Espoo, Finland 19 IQVIA, Tartu, Estonia 20 Boehringer Ingelheim International GmbH, Ingelheim, Germany 21 Boehringer Ingelheim International GmbH, US 22 Lilly Deutschland GmbH, Bad Homburg, Germany 23 Steno Diabetes Center Copenhagen, Herlev, Denmark 24 Department of Public Health, University of Copenhagen, Copenhagen, Denmark 25 Department of Cardiology, Oslo University Hospital UllevÃ¥l, and University of Oslo, Oslo, Norway 26 Lipid Clinic, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway 27 Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA 28 Department of Cardiology, Hospital ClÃnico Universitario de Valencia, INCLIVA, Universidad de Valencia, CIBER Cardiovascular, Valencia, Spain" | ||||
"Diabetes & Metabolism. 2023 Jan; 101418; ISSN 1262-3636 Virtual Conference: American Diabetes Association, 25-29 June 2021 and EASD 27 September -01 October" |
||||
, Article | ||||
, Denmark, Finland, Germany, Norway, Spain, Sweden, UK | ||||
Abstract: https://doi.org/10.1016/j.diabet.2022.101418 (https://www.sciencedirect.com/science/article/pii/S1262363622000994) | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes, Drug safety, Drug Utlization Study | 2023 | English | , Clinical setting: hospital, Clinical setting: Primary care | |
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis | ||||
Helmut Butzkueven, Jan Hillert, Merja Soilu-Hänninen, Tjalf Ziemssen, Jens Kuhle, Stig Wergeland, Melinda Magyari, Joseph R. Berger, Nicholas Moore, Aida Aydemir, Irene Bezemer & Meritxell Sabidó | ||||
"a Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia; b The Alfred Hospital, Melbourne, VIC, Australia; c Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; d Turku University Hospital Neurocenter and Division of Clinical Neurosciences, University of Turku, Turku, Finland; e Center of Clinical Neuroscience, Department of Neurology, Dresden University of Technology, Dresden, Germany; f Multiple Sclerosis Center and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland; g Department of Neurology, University Hospital and University of Basel, Basel, Switzerland; h Norwegian MS Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway; i Department of Clinical Medicine, University of Bergen, Bergen, Norway; j Danish Multiple Sclerosis Center and the Danish Multiple Sclerosis Registry, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; k Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; l Bordeaux PharmacoEpi (BPE), Universit�e de Bordeaux, Bordeaux, France; m EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA; n Global Epidemiology, IQVIA, Amsterdam, The Netherlands; o Merck Healthcare KGaA, Darmstadt, Germany" | ||||
, Article | ||||
, Australia, Denmark, Finland, Germany, Norway, Sweden, Switzerland, Turkey | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2256220 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Neurological disorders | 2023 | English | , clinical setting: Secondary care, Epidemiological study, Population Based Study | |
Burden of Hospitalizations and Outpatient Visits Associated With Moderate and Severe Acute Graft-Versus-Host Disease in Finland and Sweden: A Real-World Data Analysis | ||||
Lorenzo Sabatelli, PhD,1 Mikko Keränen, MD, PhD,2 Elisabet Viayna, PhD,3 Montserrat Roset, BSc Stats,3 Nuria Lara, MD, MSc,3 Daniel Thunström, MSc Pharm,1 Minja Pfeiffer, PhD,1 Malin Nicklasson, MSc Pharm,4 Maija Itälä-Remes, MD, PhD5 | ||||
"1Incyte Biosciences International SÃ rl, Morges, Switzerland; 2Helsinki University Hospital, Helsinki, Finland; 3IQVIA Real World Solutions, Barcelona, Spain; 4Department of Hematology and Coagulation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5Turku University Hospital, Turku, Finland " | ||||
Supportive Care in Cancer |
||||
, Article | ||||
, Finland, Spain, Sweden, Switzerland | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Transplant | 2022 | English | , Clinical setting: hospital, Observational study, Population Based Study | |
Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study | ||||
"Kerstin M G Brand, Laura Saarelainen, Jaak Sonajalg, Emmanuelle Boutmy, Caroline Foch, Marja Vääräsmäki, Laure Morin-Papunen, Judith Schlachter, CLUE Study Group, Katja M Hakkarainen, Pasi Korhonen CLUE Study Group: Minna Vehkala, Robyn Thorén, Henrik Svanström " | ||||
"Leading author: Kerstin Brand: Merck KGaA, Darmstadt, Germany IQVIA author affiliations: Global Database Studies, IQVIA, Espoo, Finland; Global Database Studies, IQVIA, Tartu, Estonia; Global Database Studies, IQVIA, Solna, Sweden; Global Database Studies, IQVIA" | ||||
BMJ Open Diab Res Care 2022;10:e002363. doi:10.1136/bmjdrc-2021-002363 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://drc.bmj.com/content/10/1/e002363.full | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Obesity | 2022 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective cohort analysis | |
The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets | ||||
Helmut Butzkueven 1 2, Nicholas Moore 3, Aida Aydemir 4, Jaak Sõnajalg 5, Irene Bezemer 6, Pasi Korhonen 7, Meritxell Sabidó 8, CLARION Study Group | ||||
1Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia. 2The Alfred Hospital, Melbourne, Australia. 3Bordeaux PharmacoEpi (BPE), Université de Bordeaux, Bordeaux, France. 4Global Biostatistics, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA (an affiliate of Merck KGaA). 5Global Database Studies, IQVIA, Tartu, Estonia. 6Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, The Netherlands. 7IQVIA (former EPID Research), Espoo, Finland. 8Global Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany. | ||||
Current Medical Research and Opinion, DOI: 10.1080/03007995.2022.2059977 |
||||
, Article | ||||
, Australia, Denmark, Finland, Germany, Norway, Sweden, Switzerland, Turkey | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/35357268/ | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Neurological disorders | 2022 | English | , clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Retrospective database analysis | |
Factors and their weight in reducing life expectancy in schizophrenia | ||||
Correll CU, Bitter I, Hoti F, Mehtälä J, Wooller A, Pungor K, Tiihonen J | ||||
1.The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA; Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany. Electronic address: ccorrell@northwell.edu. 2.Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary. 3.EPID Research, Finland (an IQVIA company). 4.Janssen, Medical Affairs EMEA, High Wycombe, United Kingdom. 5.Janssen-Cilag, Medical Affairs EMEA, Dusseldorf, Germany. 6.Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden; Neuroscience Center, Helsinki, Finland. | ||||
Schizophr Res. 2022 Nov 8;250:67-75. |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0920996422004030 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2022 | English | , clinical setting: Secondary care, Epidemiological study, Observational study | |
Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study | ||||
Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V. | ||||
"Pfizer Inc., New York, New York, United States of America. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America. EPID Research (an IQVIA company), Espoo, Finland." | ||||
Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582 |
||||
, Article | ||||
, Denmark, Finland, Netherlands , Sweden, USA | ||||
Abstract: https://onlinelibrary.wiley.com/doi/10.1002/pds.5582 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Oncology | 2022 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis | |
Metformin in pregnancy and risk of abnormal growth outcomes at birth: a register-based cohort study | ||||
Kerstin MG Brand1, Robyn Thoren2, Jaak Sõnajalg3, Emmanuelle Boutmy1, http://orcid.org/0000-0002-0254-5560Caroline Foch1, Judith Schlachter1, Katja M Hakkarainen2, Laura Saarelainen4 | ||||
Merck KGaA, Darmstadt, Germany Global Database Studies, IQVIA, Solna, Sweden Global Database Studies, IQVIA, Tartu, Estonia Global Database Studies, IQVIA, Espoo, Finland | ||||
BMJ Open Diab Res Care 2022;10:e003056. doi:10.1136/bmjdrc-2022-003056 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://drc.bmj.com/content/10/6/e003056 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2022 | English | , Observational study, Population Based Study | |
Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden | ||||
Meritxell Sabidó1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5 | ||||
1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA | ||||
ECTRIMS 2021, Digital, 13-15 October 2021 |
||||
, Abstract | ||||
, Finland, Sweden | ||||
Abstract: https://ectrims2021.abstractserver.com/program/#/details/presentations/466 | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Neurological disorders | 2021 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis | |
Interferon beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-based Drug Utilisation Study in Finland and Sweden | ||||
Meritxell Sabidó1, Kiliana Suzart-Woischnik2, Nydjie Grimes3, Lisa M Prach4, Liwei Zhao5, Katja M Hakkarainen5 | ||||
1Merck Healthcare KGaA; 2Bayer AG; 3Biogen Netherlands B.V.; 4Novartis Pharma AG; 5Global Database Studies, IQVIA | ||||
ECTRIMS 2021, Digital, 13-15 October 2021 |
||||
, Poster | ||||
, Finland, Sweden | ||||
Abstract: http://medpub-poster.merckgroup.com/ECTRIMS2021_INFORM_Study_Design.pdf | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study, Neurological disorders | 2021 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis | |
Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study | ||||
A. Karasik1 , S. Lanzinger2 , E. Chia-Hui Tan3 , D. Yabe4 , D. Jung Kim5 , W. H-H Sheu6 , C. MelzerCohen1 , R.W. Holl2 , K. Ha5 , T. Nyström7 , L. Niskanen8 , M. Linnemann Jensen9 , M.H. Kyaw10, J. Núñez11, EMPRISE EU and East Asia Study Group; | ||||
Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2 Inst. for Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine, Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical Science & Education, Södersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 9 IQVIA, Copenhagen, Denmark, 10Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital ClÃnico Universitario de Valencia, Valencia, Spain | ||||
https://doi.org/10.2337/DB21-127-LB Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021 |
||||
, Abstract | ||||
, Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan | ||||
Abstract: https://easddistribute.m-anage.com/from.storage?image=gOIMdpw6-DbPpKIQZ5HFcJGqJ2quHgbqFewkkUQkLblXdwzJ9kfmAYikI6R6NFu_GLAQJwEZKsC1PXU8ndyryA2 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes | 2021 | English | , Database Study, Methodology, Population Based Study | |
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk ofcardiovascular and renal disease among type 2 diabetes patients in routinecare in europe and israel: EMPRISE study results | ||||
T Nystroem1;AKarasik2; J Nunez3; S Lanzinger4; C Melzer-Cohen2; R W Holl4;P Casajust5; E Toresson Grip6; M Carrasco7; J Foersch8; K Karlsdotter9;M Tuovinen10; R Klement11;MHKyaw12; L Niskanen | ||||
Karolinska Institutet,Department of Clinical Science and Education, Södersjukhuset, Solna, Sweden;2Tel Aviv University, Maccabi Research and Innovation Center, Tel Aviv, Israel;3University of Valencia, Department of Cardiology, Hospital ClÃnico Universitariode Valencia, INCLIVA, CIBER Cardiovascular, Valencia, Spain;4University of Ulm,Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm, Germany;5Trial FormSupport, Real-World Evidence, Barcelona, Spain;6Swedish Institute for HealthEconomics Quantify Research, Stockholm, Sweden;7Boehringer Ingelheim EspañaS.A., Barcelona, Spain;8Boehringer Ingelheim Pharma GmbH & Co. Kg, HP CountryMedical Affairs, Ingelheim Am Rhein, Germany;9Boehringer Ingelheim AB, Stock-holm, Sweden;10Boehringer Ingelheim KY, Secondment Boehringer Ingelheim UKHEOR Team, Helsinki, Finland;11IQVIA, Global Database Studies, Tartu, Estonia;12Boehringer Ingelheim Pharmaceutical Inc., Connecticut, United States of America;13University of Eastern Finland, Kuopio, Finland; | ||||
European Journal of Heart Failure (2021)23(Suppl. S2) 2–322doi:10.1002/ejhf.2297 |
||||
, Abstract, Article | ||||
, Finland, Germany, Israel, Spain, Sweden | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.2297 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Diabetes | 2021 | English | , Database Study, Meta analysis, Methodology, Population Based Study | |
Concomitant use of drugs known to cause interactions with oral antiplatelets—polypharmacy in acute coronary syndrome outpatients in Finland | ||||
Tuire Prami, Houssem Khanfir, Pål Hasvold, Eeva Reissell, Juhani Airaksinen, Ville Kytö | ||||
Ville Kytö: Heart Center, Turku University Hospital | ||||
European Journal of Clinical Pharmacology (2020) 76:257–265 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://link.springer.com/article/10.1007/s00228-019-02777-z | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2020 | English | , Population Based Study, Retrospective database analysis | |
Hospitalizations and outpatient vists (H&OV) in moderate and severe acute graft versus host disease (aGVHD) patients in Finland and Sweden | ||||
Itälä-Remes M1, Viayna E2, Nicklasson M3, Keränen M4, Thunström D5, Pfeiffer M5, Roset M2, Lara N2, Sabatelli L5 | ||||
1 Turku University Hospital, Finland 2 IQVIA, Real World Solutions, Barcelona, Spain 3 Sahlgrenska, University Hospital, Gothenburg, Sweden 4 Helsinki University Hospital, Finland 5 Incyte Biosciences International, Morges, Switzerland | ||||
ISPOR 2020 Annual European Congress. 14-18 November 2020. Milan, Italy |
||||
, Poster | ||||
, Finland, Sweden | ||||
Abstract: x | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Transplant | 2020 | English | , Population Based Study, Retrospective cohort analysis | |
Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study | ||||
Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS. | ||||
EPID Research Oy, Espoo, Finland | ||||
BMJ |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402043/ | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2019 | English | , Epidemiological study, Retrospective database analysis | |
Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse | ||||
Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS | ||||
EPID Research Oy, Espoo, Finland | ||||
Menopause |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29994974 | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Population Based Study, Retrospective database analysis | |
Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy | ||||
Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS | ||||
EPID Research Oy, Espoo, Finland | ||||
Int Urogynecol J |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29946829 | ||||
Condition | Year | Language | Analysis type | |
, Patient Registries & Real-World Study Methods | 2019 | English | , Population Based Study, Retrospective database analysis | |
CLUE: Consequences for life of children with in utero exposure to metformin in Finland | ||||
Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen | ||||
Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen | ||||
The International Diabetes Federation (IDF) Congress 2019 |
||||
, Oral presentation | ||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis | |
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time. | ||||
Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM | ||||
VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag. | ||||
Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273. |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31210368 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis | |
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries | ||||
Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi | ||||
IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK | ||||
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA. |
||||
, Poster | ||||
, Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland | ||||
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2019 | English | , Public Health, Survey research | |
Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Pregnancy study conducted in Finland and Sweden | ||||
"Kerstin Hellwig*, Yvonne Geissbuehler2, Meritxell Sabidó3, Catrinel Popescu4, Alessandra Adamo5, Joachim Klinger6, Peter Huppke7, Asher Ornoy8, Pasi Korhonen9, Kjell-Morten Myhr10, Scott Montgomery11, Sarah Burkill11, European Interferon Beta Pregnancy Study Group" | ||||
*Katholisches Klinikum Bochum, St Josef-Hospital Universitatsklinikum, Bochum, Germany; 9StatFinn & EPID Research, Espoo, Finland | ||||
AAN, Philadelphia, USA, 4-10 May 2019 |
||||
, Oral presentation | ||||
, Europe, Finland, Nordic, Sweden | ||||
Abstract: https://n.neurology.org/content/92/15_Supplement/S49.005 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study | |
No increased risk of spontaneous abortion and ectopic pregnancy after exposure to interferon-beta prior to or during pregnancy: Results from register-based Nordic study among women with MS | ||||
R. Juuti1, K. M. Hakkarainen 1, S. Burkill 2, Y. Geissbuehler 3, M. Sabidó 4, C. Popescu 5, A. Adamo 6, J. Hillert 2, S. Cnattingius 2, M. Artama 7, A. Verkkoniemi-Ahola 8, K.-M. Myhr 9, J. Mehtälä 1, S. Bahmanyar 2, S. Montgomery 2,10, P. Korhonen 1 and the European Interferon Beta Pregnancy Study Group | ||||
1StatFinn-EPID Research, Espoo, Finland | ||||
EAN, Oslo, Norway, June 29-2 July, 2019 |
||||
, Oral presentation | ||||
, Finland, Germany, Norway, Sweden, Switzerland, UK | ||||
Abstract: https://www.ean.org/fileadmin/_files/AbstractBook/EAN_Journal_2019_Book.pdf | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: A register-based cohort study in Finland and Sweden among women with MS | ||||
Pia Vattulainen1, Sarah Burkill2, Yvonne Geissbuehler3, Meritxell Sabidó4, Catrinel Popescu5, Kiliana Suzart-Woischnik6, Kjell-Morten Myhr7, Scott Montgomery2,8, Pasi Korhonen1 the European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group | ||||
1StatFinn-EPID Research, Espoo, Finland | ||||
ECTRIMS, Stockholm, Sweden, 11-13 September, 2019 |
||||
, Poster | ||||
, Finland, Nordic, Sweden | ||||
Abstract: https://onlinelibrary.ectrims-congress.eu/ectrims/2019/stockholm/278346/pasi.korhonen.prevalence.of.infant.outcomes.at.birth.after.exposure.to.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmontgomery | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2019 | English | , Epidemiological study, Population Based Study, Retrospective cohort analysis | |
Assessing the Outcomes for Orphan Status or Accelerated Assessment EMA Approved Medicines: A Comparison of Health Technology Assessment in Denmark, Finland, Norway and Sweden | ||||
Falla, Edel; Pitcher, Ashley; Acs, Annabel; Heller, Vincent; Zhang, Rongrong | ||||
IQVIA, Real-World Insights, London, LON, UK IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Copenhagen, Denmark IQVIA, Real-World Insights, Solna, AB, Sweden IQVIA, Real-World Insights, Stockholm, Sweden | ||||
ISPOR Europe 2019, November 5, 2019, Copenhagen, Denmark |
||||
, Poster | ||||
, Denmark, Finland, Nordic, Norway, Sweden | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)34089-6/fulltext?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1098301519340896%3Fshowall%3Dtrue#%20 | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment | 2019 | English | , Review | |
Verihiutaleiden estäjähoito toteutuu vajavaisesti sepelvaltimotautikohtauksen jälkeen | ||||
Eeva Reissell, Ville Kytö, Juha Halme, Tuire Prami, Sonja Lumme, Juhani Airaksinen | ||||
Eeva Reissell: National Institute for Health and Welfare | ||||
Lääkärilehti.2019; 43: 2449-54. |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.laakarilehti.fi/tieteessa/alkuperaistutkimukset/verihiutaleiden-estajahoito-toteutuu-vajavaisesti-sepelvaltimotautikohtauksen-jalkeen/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | Finnish | , Population Based Study, Retrospective database analysis | |
Usage of PCI and long-term cardiovascular risk in post-myocardial infarction patients: a nationwide registry cohort study from Finland | ||||
Ville Kytö, Tuire Prami, Houssem Khanfir, Pål Hasvold, Eeva Reissell, Juhani Airaksinen | ||||
Ville Kytö: Turku University Hospital and University of Turku | ||||
BMC Cardiovascular Disorders (2019) 19:123 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-1101-8 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2019 | English | , Population Based Study, Retrospective database analysis | |
Patient and caregiver indirect costs after acute cardiovascular events in Europe. | ||||
Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5 | ||||
1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium | ||||
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
, Oral presentation | ||||
, Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia | ||||
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
Feasibility Assessment for Conducting a Multi-Country Post-Marketing Safety Oncology Study Using Secondary Data Sources in Europe | ||||
Wells KE, Jiang R, Tyczynski JE, Secrest M, Oliveria SA | ||||
Wells KE: IQVIA; Jiang R: Abbvie; Tyczynski JE: Abbvie; Secrest M: IQVIA; Oliveria SA: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, Denmark, Finland, Germany, Norway, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Oncology, Patient Registries & Real-World Study Methods | 2018 | English | , Database Study, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis, Review | |
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder | ||||
Lähteenvuo M, Tanskanen A, Taipale H | ||||
Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland | ||||
JAMA Psychiatry (2018); 75(4):347-355 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2673379 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2018 | English | , Prospective study | |
Different patterns of second?line treatment in type 2 diabetes after metformin monotherapy in Denmark, Finland, Norway and Sweden (D360 Nordic): A multinational observational study | ||||
Persson F, Bodegard J, Lahtela JT, Nyström T, Jørgensen ME, Jensen ML, Gulseth HL, Thuresson M, Hoti F, Nathanson D, Norhammar A, Birkeland KI, Eriksson JG, Eriksson JW | ||||
StatFinn & EPID Research, Espoo, Finland | ||||
Endocrinol Diabetes Metab. |
||||
, Article | ||||
, Denmark, Finland, Nordic, Norway, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354817/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Population Based Study, Retrospective database analysis | |
Insulins NPH, glargine, and detemir, and risk of severe hypoglycemia among working-age adults | ||||
Strandberg AY, Khanfir H, Mäkimattila S, Saukkonen T, Strandberg TE, Hoti F | ||||
University of Helsinki, Clinicum, Helsinki, Finland, Aava Medical Centre, Kerava, Finland | ||||
Ann Med. (2017) 49(4):357-364 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.tandfonline.com/doi/abs/10.1080/07853890.2016.1278302?journalCode=iann20 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
JHEOR 2017;5(1):89-108 |
||||
, Article | ||||
, Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
COMMONALITIES AND DIFFERENCES IN DATA COLLECTION ACROSS EUROPEAN SPONDYLOARTHRITIS REGISTRIES | ||||
M. L. Hetland* 1, M. Østergaard1, J. Askling2, C. Gabay3, D. Nordstrom4, O. FitzGerald5, M. Hernández Miguel6, M. Santos7 , Z. Rotar8, H. Mann9, F. Iannone10, M. J. Nissen3, E. Hauge1, J. Gomez-Reino11, F. DÃaz-González12, M. Tomsic8, K. Pavelka9, F. O'Shea5, C. Sullivan5, M. van de Sande13, I. E. van der Horst-Bruinsma13, G. J. Macfarlane14, G. T. Jones14, B. Gudbjørnsson15, T. K. Kvien16 on behalf of EuroSpA Study Group | ||||
1DANBIO, Glostrup, Denmark, 2ARTIS, Stockholm, Sweden, 3SCQM, Geneva, Switzerland, 4ROB-FIN, Helsinki, Finland, 5ASRI, Dublin, Ireland, 6BIOBADASER, Barcelona, Spain, 7reuma.pt, Almada, Portugal, 8biorx.si, Ljubljana, Slovenia, 9ATTRA, Prague, Czech Republic, 10GISEA, Bari, Italy, 11BIOBADASER, Santiago, 12BIOBADASER, Santa Cruz de Tenerife, Spain, 13ARC, Amsterdam, Netherlands, 14BSRBR-AS, Aberdeen, United Kingdom, 15ICEBIO, Reykjavik, Iceland, 16NORDMARD, Oslo, Norway | ||||
EULAR, Madrid, 2017 |
||||
, Abstract | ||||
, Czech, Denmark, Finland, Ireland, Italy, Norway, Slovenia, Spain, Sweden, Switzerland | ||||
Abstract: http://ard.bmj.com/content/76/Suppl_2/656.3 | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2017 | English | , Epidemiological study | |
Pioglitazone Use and Risk of Bladder Cancer: A Systematic Literature Review and Meta-Analysis of Observational Studies | ||||
Hoti F, Mehtälä J, Khanfir H, Christopher S, Bennett D, Ye Y, Korhonen P | ||||
EPID Research, Espoo, Finland | ||||
Pharmacoepidemiology and Drug Safety (2017);26 (S2): 3-636 |
||||
, Abstract | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4275 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Literature Review, Meta analysis | |
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study | ||||
Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M | ||||
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden | ||||
European Neuropsychopharmacology(2017);27(4): S855–S856 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)31536-5/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective database analysis | |
Real-world effectiveness of antipsychotic treatments among patients with schizophrenia and affective symptoms | ||||
Tiihonen J, Lähteenvuo M, Hoti F, Vattulainen P, Taipale H, Tanskanen A | ||||
Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden | ||||
European psychiatry (2017); 41:S386 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.europsy-journal.com/article/S0924-9338(17)32698-6/pdf | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective database analysis | |
Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry | ||||
Lehto M, Niiranen J, Korhonen P, Mehtälä J, Khanfir H, Hoti F, Lassila R, Raatikainen P | ||||
Department of Cardiology, Heart and Lung Center, University of Helsinki, Helsinki University Hospital, Helsinki, Finland | ||||
Pharmacoepidemiology & Drug Safety (2017);26(6): pp. 657-665 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4194 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Retrospective database analysis | |
Lower Death Risk for Vascular Dementia Than for Alzheimer’s Disease With Postmenopausal Hormone Therapy Users | ||||
Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland | ||||
The Journal of Clinical Endocrinology & Metabolism (2017);102(3):870-877 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://academic.oup.com/jcem/article/102/3/870/3061928 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study | |
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study | ||||
Strongman H, Korhonen P, Williams R, Bahmanyar S, Hoti F, Christopher S, Majak M, Kool-Houweling L, Linder M, Dolin P, Heintjes EM | ||||
EPID Research, Espoo, Finland | ||||
BMJ Open Diab Res Care (2017);5: p. e000364-e000364 |
||||
, Article | ||||
, Finland, Netherlands, Sweden, UK | ||||
Abstract: https://drc.bmj.com/content/5/1/e000364 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Epidemiological study, Retrospective database analysis | |
Real-world effectiveness of antipsychotic treatments among patients with schizophrenia and affective symptoms | ||||
Tiihonen J, Lähteenvuo M, Hoti F, Vattulainen P, Taipale H, Tanskanen A | ||||
Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden | ||||
European Psychiatry (2017) 41 (Supplement): S386 |
||||
, Abstract | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0924933817326986 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study | ||||
Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M | ||||
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden | ||||
The Lancet Psychiatry (2017) 4(7):547-553 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S2215036617301347?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2017 | English | , Population Based Study, Retrospective database analysis | |
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
Clinical Epidemiology |
||||
, Article | ||||
, Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review | |
Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies | ||||
Savolainen-Peltonen H, Tuomikoski P, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS | ||||
Obstetrics and Gynecology (H.S.-P., P.T., O.Y., T.S.M.), University of Helsinki and Helsinki University Hospital, Haartmaninkatu 2, 00029 Helsinki, Finland; Folkhälsan Research Center (H.S.-P., T.S.M.), Biomedicum, Haartmaninkatu 8, 00029 Helsinki, Finland; | ||||
The Journal of Clinical endocrinology and metabolism (2016); 101(7): 2794-801 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://academic.oup.com/jcem/article/101/7/2794/2810371#59805854 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Adjusting for the Effect of Switching Basal Insulin Treatment on the Risk of First Severe Hypoglycaemia | ||||
Khanfir H, Korhonen P, Mäkimattila S, Hoti F | ||||
EPID Research, Espoo, Finland | ||||
Pharmacoepidemiology and Drug Safety (2016); 25(S3): 3-679 |
||||
, Abstract | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4070 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2016 | English | , Population Based Study, Retrospective database analysis | |
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries | ||||
Korhonen P, Heintjes E M, Williams R, Hoti F, Christopher S, Majak M, Kool-Houweling L, Strongman H, Linder M, Dolin P, Bahmanyar S | ||||
EPID Research Ltd, Espoo, Finland | ||||
BMJ (2016);354:i3903 |
||||
, Article | ||||
, Finland, Netherlands, Sweden, UK | ||||
Abstract: https://researchonline.lshtm.ac.uk/4646203/1/Pioglitazone%20use%20and%20risk_GOLD%20VoR.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2016 | English | , Population Based Study, Retrospective cohort analysis | |
The Quality of Warfarin Therapy Among Atrial Fibrillation Patients in Finland ? Results from the FinWAF Registry | ||||
Mehtälä J, Raatikainen P, Lassila R, Khanfir H, Korhonen P, Hoti F, Lehto M | ||||
EPID Research, Espoo, Finland | ||||
Pharmacoepidemiology and Drug Safety (2016);25(Suppl. 3): pp. 3-680 |
||||
, Abstract | ||||
, Finland, Nordic | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.4070 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study | ||||
Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland | ||||
Menopause (2016);23(11):1199-1203 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27465718 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Vaginal estradiol use and the risk for cardiovascular mortality | ||||
Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland | ||||
Human Reproduction (2016);31(4):804-9 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://academic.oup.com/humrep/article/31/4/804/2380118 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland | ||||
Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J | ||||
EPID Research, Espoo, Finland | ||||
BMJ Open (2016) 6:e012604 |
||||
, Article | ||||
, Finland, Nordic | ||||
Abstract: https://bmjopen.bmj.com/content/6/11/e012604.short | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Age predicts initiation of and persistence with P2Y12 inhibitor treatment after acute coronary syndrome - results form a nationwide retrospective cohort in Finland | ||||
Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J | ||||
EPID Research, Espoo, Finland | ||||
European Heart Journal (2016 );37 ( Abstract Supplement ):939 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://esc365.escardio.org/Congress/ESC-CONGRESS-2016/Poster-session-5-Are-we-better-at-managing-cardiovascular-disease-in-the-el/139119-age-predicts-initiation-of-and-persistence-with-p2y12-inhibitor-treatment-after-acute-coronary-syndrome-results-from-a-nationwide-retrospective-cohort-in-finland | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Population Based Study, Retrospective database analysis | |
Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland. | ||||
Prami T, Khanfir H, Deleskog A, Hasvold P, Kytö V, Reissell E, Airaksinen J. | ||||
EPID Research, Espoo, Finland | ||||
European Heart Journal (2016);37(Abstract Supplement);378-379 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://esc365.escardio.org/Congress/ESC-CONGRESS-2016/Poster-session-2-Clinical-platelet-studies/140660-gender-differences-in-oral-antiplatelet-treatment-use-results-from-a-nationwide-cohort-study-of-acute-coronary-syndrome-patients-in-finland | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Use of Contraindicated Drugs in Pediatric Outpatients in the Nordic Countries | ||||
Prami T, Långström D, Iso-Mustajärvi I, Sandler N | ||||
EPID Research, Espoo, Finland | ||||
Pharmacoepidemiology and Drug Safety (2016):25 (S3): pp. 3-679 |
||||
, Abstract | ||||
, Denmark, Finland, Norway, Sweden | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4070 | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics | 2016 | English | , Retrospective database analysis | |
All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine | ||||
Strandberg AY, Hoti FJ, Strandberg TE, Christopher S, Haukka J, Korhonen P | ||||
University of Helsinki, Clinicum, Helsinki, Finland, Aava Medical Centre, Kerava, Finland | ||||
PLoS ONE (2016);11(3): e0151910 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0151910 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2016 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Real-world effectiveness of pharmacological treatments in severe unipolar depression in a nationwide cohort of 123,712 patients | ||||
Tiihonen J, Lähteenvuo M, Hoti F, Vattulainen P, Tanskanen A | ||||
Karolinska Institutet, Stockholm, Sweden | ||||
Neuropsychopharmacology (2016);41: S289–S454. Poster T115. |
||||
, Poster | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149585/pdf/npp2016241a.pdf | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2016 | English | , Population Based Study, Retrospective database analysis | |
Reduced risk of breast cancer mortality in women using postmenopausal hormone therapy: a Finnish nationwide comparative study | ||||
Mikkola TS, Savolainen-Peltonen H, Tuomikoski P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O. | ||||
Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland | ||||
Menopause (2016) 23(11): 1199-1203 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://journals.lww.com/menopausejournal/Abstract/2016/11000/Reduced_risk_of_breast_cancer_mortality_in_women.8.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Population Based Study, Prospective study | |
Vaginal estradiol use and the risk for cardiovascular mortality | ||||
Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki University, PO Box 140, 00029 HUS Helsinki, Finland | ||||
Human Reproduction (2016);31(4): 804-9 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://academic.oup.com/humrep/article/31/4/804/2380118 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | , Epidemiological study, Population Based Study, Prospective study | |
Bladder Cancer Risk in Relation to Exposure to Pioglitazone among Patients with T2DM in the Pan European Multi-Database Bladder Cancer Risk Characterisation Study | ||||
Korhonen P, Haukka J, Tayler M, Haddad PM, Patel MX, Tiihonen J | ||||
EPID Research Ltd, Espoo, Finland | ||||
American Diabetes Association's 75th Scientific Session, Boston, USA, 5-9 June, 2015 |
||||
, Finland, Netherlands, Sweden, UK | ||||
Abstract: https://ada.scientificposters.com/epsAbstractADA.cfm?id=1 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Population Based Study, Retrospective database analysis | |
Entacapone and Prostate Cancer Risk in Patients With Parkinson's Disease | ||||
Korhonen P, Kuoppamäki M, Prami T, Hoti F, Christopher S, Ellmén J, Aho V, Vahteristo M, Pukkala E, Haukka J | ||||
EPID Research Ltd, Espoo, Finland | ||||
Movement disorders (2015);30(5):724-8. |
||||
, Abstract | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/mds.26140 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2015 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Children's medication in the Nordic countries - Survey on national administrative register data | ||||
Långström D, Iso-Mustajärvi I, Sandler N, Prami T | ||||
Pharmaceutical Sciences Laboratory, Ã…bo Akademi University, Turku, Finland | ||||
Value in Health November 2015; 18 (7):A745–A746 |
||||
, Poster | ||||
, Finland, Sweden | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(15)04957-8/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Pediatrics | 2015 | English | , Population Based Study, Retrospective database analysis | |
Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality | ||||
Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland | ||||
Menopause (2015);22(9):976-83 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://insights.ovid.com/pubmed?pmid=25803671 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy | ||||
Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, 00029 Helsinki, Finland | ||||
The Journal of Clinical Endocrinology & Metabolism (2015);100(12): 4588-94 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26414962 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women's Health Initiative: A cohort study | ||||
Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS | ||||
Department of Obstetrics and Gynecology, Helsinki University Hospital, PO Box 140, 00029 HUS, Helsinki, Finland | ||||
Maturitas (2015);81(3): 384-8. |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0378512215006398 | ||||
Condition | Year | Language | Analysis type | |
, Stroke and other CNS | 2015 | English | , Population Based Study, Retrospective cohort analysis | |
Poor Quality of Warfarin Therapy is Associated with Elevated Risk Of Myocardial Infarction in Patients with Atrial Fibrillation. Results From the FinWAF Registry with 54568 Patients | ||||
Raatikainen P, Niiranen J, Korhonen P, Mehtälä J, Khanfir H, Lassila R, Lehto M | ||||
Univ of Eastern Finland, Jyväskylä, Finland | ||||
American Heart Association's Scientific Session 2015, Orlando, US, 12-16 November, 2015: Poster no. S4064 |
||||
, Poster | ||||
, Finland | ||||
Abstract: https://aha.scientificposters.com/epsAbstractAHA.cfm?id=1 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Retrospective database analysis | |
Psychotropic drugs and homicide: a prospective cohort study from Finland | ||||
Tiihonen J, Lehti M, Aaltonen M, Kivivuori J, Kautiainen H, Virta L, Hoti F, Tanskanen A, Korhonen P | ||||
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden | ||||
World Psychiatry. (2015) 14(2):245-7 |
||||
, Letter | ||||
, Finland, Nordic | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/wps.20220 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2015 | English | , Population Based Study, Prospective study | |
Increased Cardiovascular Mortality Risk in Women Discontinuing Postmenopausal Hormone Therapy | ||||
Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Department of Obstetrics and Gynecology (T.S.M., P.T., O.Y.), Helsinki University Hospital, 00029 Helsinki, Finland | ||||
The Journal of Clinical Endocrinology and Metabolism (2015);100(12):4588-94 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://academic.oup.com/jcem/article/100/12/4588/2536376 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Population Based Study, Prospective study | |
Estradiol-based postmenopausal hormone therapy and risk of cardiovascular and all-cause mortality | ||||
Mikkola TS, Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O | ||||
Department of Obstetrics and Gynecology, Helsinki University, Helsinki University Hospital, Helsinki, Finland | ||||
Menopause (2015);22(9): 976-83 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://journals.lww.com/menopausejournal/Abstract/2015/09000/Estradiol_based_postmenopausal_hormone_therapy_and.9.aspx | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Population Based Study, Prospective study | |
The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women’s Health Initiative: A cohort study | ||||
Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS | ||||
Department of Obstetrics and Gynecology, Helsinki University Hospital, PO Box 140, , 00029 HUS Helsinki, Finland | ||||
Maturitas. (2015) 81(3):384-8 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S0378512215006398?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Stroke and other CNS | 2015 | English | , Population Based Study, Retrospective cohort analysis | |
Regional assessment of severe hypoglycemic coma events in Finland | ||||
Vattulainen P, Mushnikov V, Hoti F, Saukkonen T, Korhonen P. | ||||
EPID Research, Espoo, Finland | ||||
Value Health. (2014) 17(7): A332 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Epidemiological study, Observational study, Population Based Study | |
Regional Assessment of Severe Hypoglycemic Coma Events in Finland | ||||
Hoti F, Vattulainen P, Mushnikov V, Saukkonen T, Korhonen P | ||||
EPID Research, Espoo, Finland | ||||
Value in Health (2014);17(7):A332 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02557-1/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Epidemiological study, Observational study, Population Based Study | |
Entacapone does not increase prostate cancer risk of mortality in patients with Parkinson's disease | ||||
Korhonen P, Kuoppamäki M, Prami T, Hoti F, Christopher S, Ellmén J, Aho V, Vahteristo M, Pukkala E, Haukka J | ||||
EPID Research, Espoo, Finland | ||||
Value in Health November (2014);17(7):Page A393 |
||||
, Poster | ||||
, Finland | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02800-9/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2014 | English | , Epidemiological study, Population Based Study, Retrospective cohort analysis | |
Entacapone did not Increase Prostate Cancer Risk or Mortality in Patients with Parkinson's Disease | ||||
Korhonen P, Kuoppamäki M, Prami T, Hoti F, Christopher S, Ellmén J, Aho V, Vahteristo M, Pukkala E, Haukka J | ||||
EPID Research Ltd, Espoo, Finland | ||||
Value in Health (2014);17(7):A393 |
||||
, Poster | ||||
, Finland | ||||
Abstract: https://ac.els-cdn.com/S1098301514028009/1-s2.0-S1098301514028009-main.pdf?_tid=bb424a19-00f9-4521-b077-040dbc4ea573&acdnat=1537864925_ab1c4e0b46d54bf47adedb9937c77df5 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2014 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Lower Risk of Mortality in Patients with Type 2 Diabetes Using Insulins Detemir or Glargine Compared to NPH: A Propensity Score Matched Nationwide Register Study in Finland | ||||
Mäkimattila S, Hoti F, Christopher S, Haukka J, Korhonen P, Saukkonen T | ||||
EPID Research Ltd, Espoo, Finland | ||||
Diabetes (2014);63 (Suppl 1):A343-A425 |
||||
, Poster | ||||
, Finland, Nordic | ||||
Abstract: http://diabetes.diabetesjournals.org/mwg-internal/de5fs23hu73ds/progress?id=tLDZcQ3XmqwM1R5WmUnmnK6ZYf5Vk0j-7PYr0VdNiOQ,&dl | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Retrospective database analysis | |
Lower Risk of Mortality in Patients with Type 2 Diabetes Using Insulins Detemir or Glargine Compared to NPH: A Propensity Score Matched Nationwide Register Study in Finland | ||||
Mäkimattila S, Hoti F, Christopher S, Haukka J, Korhonen P, Saukkonen T | ||||
EPID Research Ltd, Espoo, Finland | ||||
American Diabetes Association 74th Scientific Session, San Francisco, USA, 13-17 June, 2014 |
||||
, Poster | ||||
, Finland | ||||
Abstract: https://ada.scientificposters.com/epsAbstractADA.cfm?id=1 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Retrospective database analysis | |
Coronary Heart Disease Mortality and Hormone Therapy Before and After the Women's Health Initiative | ||||
Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS | ||||
Department of Obstetrics and Gynecology, Helsinki University Hospital, PO Box 140, 00029 HUS, Helsinki, Finland | ||||
Obstetrics & Gynecology (2014);124(5):947-53 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://journals.lww.com/greenjournal/Fulltext/2014/11000/Coronary_Heart_Disease_Mortality_and_Hormone.13.aspx | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Uses of Electronic Patient Information Systems and National Registers ? Implementation of the Clinical Practice Guideline and Evaluation of Costs and Use of Resources in Patients with Incident Type 2 Diabetes in Finland | ||||
Prami T, Sulamaa A, Sipilä R, Linna M, Hahl J, Miettinen T, Leppä E, Haukka J, Tuomilehto J, Enlund H, Niskanen L, Korhonen P | ||||
EPID Research, Espoo, Finland | ||||
Value in Health. (2014);17(7): A336 |
||||
, Abstract | ||||
, Finland, Nordic | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(14)02579-0/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Population Based Study | |
Coronary heart disease mortality and hormone therapy before and after the women's health initiative | ||||
Tuomikoski P, Lyytinen H, Korhonen P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola S. | ||||
Department of Obstetrics and Gynecology, Helsinki University Central Hospital, the National Institute for Health and Welfare, and the Folkhälsan Research Center, Helsinki, and the EPID Research Oy, Espoo, Finland; and the Nordic School of Public Health, Gothenburg, Sweden | ||||
Obstet Gynecol. (2014) 124:947-953 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://journals.lww.com/greenjournal/fulltext/2014/11000/Coronary_Heart_Disease_Mortality_and_Hormone.13.aspx | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Population Based Study, Retrospective database analysis | |
Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study | ||||
Haukka J, Hoti F, Erästö P, Saukkonen T, Mäkimattila S, Korhonen P | ||||
EPID Research Ltd, Espoo, Finland | ||||
Pharmacoepidemiology and drug safety (2013); 22: 1326-1335 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265848/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Retrospective database analysis | |
Description of long-term polypharmacy among schizophrenia outpatients | ||||
Suokas JT, Suvisaari JM, Haukka J, Korhonen P, Tiihonen J | ||||
Department of Mental Health and Alcohol Research, National Institute for Health and Welfare, Helsinki, Finland | ||||
Soc Psychiatry Psychiatr Epidemiol. (2013) 48 (4): pp. 631-638 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://link.springer.com/article/10.1007/s00127-012-0586-6 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2013 | English | , Population Based Study, Prospective study | |
Comparative analysis of Streptococcus pneumoniae transmission in Portuguese and Finnish day-care centres | ||||
Pessoa D, Hoti F, Syrjänen R, Sá-Leão R, Kaijalainen T, Gabriela M, Gomes M, Auranen K | ||||
Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland and Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland | ||||
BMC Infect Dis. |
||||
, Article | ||||
, Finland, Portugal | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652738/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2013 | English | , Longitudinal study | |
The risk of first severe hypoglycaemia depends on the type of basal insulin but does not differ between patients with type 1 and type 2 diabetes: The EpiHypo Study | ||||
Korhonen P, Haukka J, Hoti F, Erästö P, Mäkimattila S, Saukkonen T | ||||
EPID Research Ltd, Espoo, Finland | ||||
Diabetologia (2012);55: (Suppl 1): S254 |
||||
, Poster | ||||
, Finland | ||||
Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/the-risk-of-first-severe-hypoglycaemia-depends-on-the-type-of-basal-insulin-but-does-not-differ-between-patients-with-type-1-and-type-2-diabetes-the-epihypo-study--2 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis | |
Type of Insulin and Age are Predictors of Hospitalization due to Severe Hypoglycemia: The EpiHypo Study | ||||
Mäkimattila S, Korhonen P, Haukka J, Hoti F, Pajunen P, Saukkonen T | ||||
EPID Research Ltd, Espoo, Finland | ||||
Diabetes (2012);61:A101-A102 |
||||
, Poster | ||||
, Finland | ||||
Abstract: http://diabetes.diabetesjournals.org/content/diabetes/61/Supplement_1/A99.full.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective database analysis | |
Risk of First Severe Hypoglycaemic (SH) Coma Event among Patients with Diabetes Who Initiate the Use of Detemir (IDet), Glargine (IGla) and NPH Insulins: A Nationwide Register-Linkage Study in Finland | ||||
Korhonen P, Hoti F, Erästö P, Mäkimattila S, Saukkonen T, Haukka J | ||||
EPID Research Ltd, Espoo, Finland | ||||
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012) 21: (Suppl 3): 27-27 |
||||
, Abstract | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/epdf/10.1002/pds.3324 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Population Based Study, Retrospective database analysis | |
Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia | ||||
Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P | ||||
Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, FI-70240 Kuopio, Finland | ||||
Arch Gen Psychiatry. (2012) 69(5):476-83 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1151489 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2012 | English | , Population Based Study, Prospective study | |
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia | ||||
Tiihonen J, Haukka J, Taylor M, Haddad PM, Patel MX, Korhonen P | ||||
Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland | ||||
The American Journal of Psychiatry (2011) 168(6):603-9 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2011.10081224 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2011 | English | , Population Based Study, Prospective study | |
Incidence of cancer and statin usage—record linkage study | ||||
Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J | ||||
Data Analysis and Interpretation Group, International Agency for Research on Cancer, Helsinki, Finland | ||||
International Journal of Cancer (2010); 126(1):279-84 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.24536 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Epidemiological study, Population Based Study, Retrospective cohort analysis | |
Incidence of cancer and antidepressant medication: Record linkage study | ||||
Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J | ||||
Data Analysis and Interpretation Group, International Agency for Research on Cancer, Helsinki, Finland | ||||
International Journal of Cancer (2010);126(1):285-96 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.24537 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2010 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
Daily costs of Prostaglandin analogues as monotherapy or in fixed combinations with Timolol, in Denmark, Finland, Germany and Sweden | ||||
Bergstrom A1, Maurel F2, Le Pen C3, Lamure E2, Kent M4, Bardoulat I2,Berdeaux GH5,6 | ||||
1 Lund Hospital, Lund, Sweden 2 IMS France, Puteaux, France 3 Université Paris-Dauphine, Paris, France 4 Alcon Inc, Fort Worth, Texas, USA 5 Alcon France SA, Rueil-Malmaison, France 6Conservatoire National des Arts et Métiers, Paris, France | ||||
Clin Ophthalmol. 2009;3:471-81 |
||||
, Article | ||||
, Denmark, Finland, Germany, Nordic, Sweden | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732058/?tool=pubmed | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2009 | English | , Economic evaluation | |
Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort | ||||
Haukka J, Arffman M, Partonen T, Sihvo S, Elovainio M, Tiihonen J, Lönnqvist J, Keskimäki I | ||||
National Institute for Health and Welfare, Helsinki, Finland | ||||
European Journal of Clinical Pharmacology (2009); 65(7):715-20 |
||||
, Article | ||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2009 | English | , Epidemiological study, Population Based Study, Retrospective database analysis | |
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study) | ||||
Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J | ||||
Department of Forensic Psychiatry, University of Kuopio and Niuvanniemi Hospital, Department of Clinical Physiology, Kuopio University Hospital, Kuopio, Finland | ||||
Lancet. (2009) 374(9690):620-7. |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.sciencedirect.com/science/article/pii/S014067360960742X?via%3Dihub | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2009 | English | , Population Based Study | |
Outbreaks of Streptococcus pneumoniae carriage in day care cohorts in Finland - implications for elimination of transmission | ||||
Hoti F, Erästö P, Leino T, Auranen K | ||||
Department of Vaccination and Immune Protection, Division of Health Protection, National Institute for Health and Welfare (THL), Helsinki, Finland. | ||||
BMC Infect Dis. |
||||
, Article | ||||
, Finland | ||||
Abstract: https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-9-102 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2009 | English | , Longitudinal study, Population Based Study | |
Cost-effectiveness of fentanyl ITS (Ionsys TM) in post-operative pain management: a Finnish hospital perspective analysis. | ||||
Van den Steen D1, Van Bellinghen LA1, Liwing J2, Van Vlaenderen I1, Lamotte M1, Lothgren M2, Annemans L3 | ||||
1 IMS Health, Brussels, Belgium 2 Janssen- Cilag, Sollentuna, Sweden 3 Ghent University, Ghent, Belgium | ||||
ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece |
||||
, Oral presentation | ||||
, Finland | ||||
Condition | Year | Language | Analysis type | |
, Surgery | 2008 | English | , Cost effectiveness | |
Association between medication and risk of suicide, attempted suicide and death in nationwide cohort of suicidal patients with schizophrenia | ||||
Haukka J, Tiihonen J, Härkänen T, Lönnqvist J | ||||
National Public Health Institute, FIN-00300 Helsinki, Finland | ||||
Pharmacoepidemiology Drug Safety (2008);17(7):686-96 |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/18327869 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2008 | English | , Epidemiological study, Observational study, Population Based Study | |
Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres | ||||
Leino T, Hoti F, Syrjänen R, Tanskanen A, Auranen K | ||||
National Public Health Institute (KTL), Mannerheimintie 166, FIN-00300 Helsinki, Finland | ||||
BMC Infect Dis. |
||||
, Article | ||||
, Finland | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639357/ | ||||
Condition | Year | Language | Analysis type | |
2008 | English | , Longitudinal study | ||
Adaptation of a health economic model of the natural history of HPV infection and cervical cancer in a well functioning population-based screening system ? a model calibration to Finland | ||||
Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Evaluating the clinical effects and the cost-effectiveness of prophylactic cervical cancer vaccination within an organised population-based screening setting ? case Finland | ||||
Saku Torvinen, Pekka Nieminen, Nadia Demarteau, Susanne Bergius, Jarmo Hahl | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Finland, Nordic | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |